» Articles » PMID: 31972238

High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice

Overview
Specialty Gastroenterology
Date 2020 Jan 24
PMID 31972238
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The relationship between serum cholesterol level and development of hepatocellular carcinoma (HCC) remains unclear. We investigated the effects of serum cholesterol level on development of liver tumors in mice.

Methods: We performed studies with C57BL/6J mice, mice with disruption of the low-density lipoprotein receptor gene (Ldlrmice), and mice with conditional deletion of nature killer (NK) cells (NK mice). Some C57BL/6J and NK mice were given injections of diethylinitrosamine to induce liver tumor formation. Mice were placed on a normal diet (ND) or high-cholesterol diet (HCD) to induce high serum levels of cholesterol. We also studied mice with homozygous disruption of ApoE (ApoE mice), which spontaneously develop high serum cholesterol. C57BL/6J and NK mice on the ND or HCD were implanted with Hep1-6 (mouse hepatoma) cells and growth of xenograft tumors and lung metastases were monitored. Blood samples were collected from mice and analyzed by biochemistry and flow cytometry; liver and tumor tissues were collected and analyzed by histology, immunohistochemistry, and RNA-sequencing analysis. NK cells were isolated from mice and analyzed for cholesterol content, lipid raft formation, immune signaling, and changes in functions. We obtained matched tumor tissues and blood samples from 30 patients with HCC and blood samples from 40 healthy volunteers; levels of cholesterol and cytotoxicity of NK cells were measured.

Results: C57BL/6J mice on HCD and ApoE mice with high serum levels of cholesterol developed fewer and smaller liver tumors and lung metastases after diethylinitrosamine injection or implantation of Hep1-6 cells than mice on ND. Liver tumors from HCD-fed mice and ApoE mice had increased numbers of NK cells compared to tumors from ND-fed mice. NK mice or mice with antibody-based depletion for NK cells showed similar tumor number and size in ND and HCD groups after diethylinitrosamine injection or implantation of Hep1-6 cells. NK cells isolated from C57BL/6J mice fed with HCD had increased expression of NK cell-activating receptors (natural cytotoxicity triggering receptor 1 and natural killer group 2, member D), markers of effector function (granzyme B and perforin), and cytokines and chemokines compared with NK cells from mice on ND; these NK cells also had enhanced cytotoxic activity against mouse hepatoma cells, accumulated cholesterol, increased lipid raft formation, and immune signaling activation. NK cells isolated from HCD-fed Ldlr mice did not have increased cholesterol content or cytotoxic activity against mouse hepatoma cells compared with ND-fed Ldlr mice. Serum levels of cholesterol correlated with number and activity of NK cells isolated from human HCCs.

Conclusions: Mice with increased serum levels of cholesterol due to an HCD or genetic disruption of ApoE develop fewer and smaller tumors after injection of hepatoma cells or a chemical carcinogen. We found cholesterol to accumulate in NK cells and activate their effector functions against hepatoma cells. Strategies to increase cholesterol uptake by NK cells can be developed for treatment of HCC.

Citing Articles

Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.

Xie X, Liu W, Yuan Z, Chen H, Mao W Mol Cancer. 2025; 24(1):71.

PMID: 40057791 PMC: 11889836. DOI: 10.1186/s12943-025-02269-y.


Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study.

Ning L, Gao Z, Chen D, Han J, Xie G, Sun J BMC Cancer. 2025; 25(1):389.

PMID: 40038628 PMC: 11877886. DOI: 10.1186/s12885-025-13690-3.


Lipid Metabolism in Breast Cancer: From Basic Research to Clinical Application.

Huang X, Liu B, Shen S Cancers (Basel). 2025; 17(4).

PMID: 40002245 PMC: 11852908. DOI: 10.3390/cancers17040650.


Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation.

Zhang Y, Alzahrani M, Dambaeva S, Kwak-Kim J Semin Immunopathol. 2025; 47(1):18.

PMID: 39966179 DOI: 10.1007/s00281-025-01043-y.


Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity.

Gui L, Chen K, Yan J, Chen P, Gao W, Ma B Cell Rep Med. 2025; 6(2):101913.

PMID: 39824180 PMC: 11866496. DOI: 10.1016/j.xcrm.2024.101913.